Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Łukawska M[au]:

Dopa-responsive dystonia or early-onset Parkinson disease - Genotype-phenotype correlation. Potulska-Chromik A et al. Neurol Neurochir Pol. (2017)

Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking. Szafraniec E et al. Spectrochim Acta A Mol Biomol Spectrosc. (2016)

<i>In Vitro</i> Antileukemic Activity of Formamidine Epidoxorubicin Analogs. Mazur L et al. Anticancer Res. (2017)

Search results

Items: 25

1.

Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death.

Rogalska A, Gajek A, Łukawska M, Oszczapowicz I, Marczak A.

PLoS One. 2018 Jul 24;13(7):e0201296. doi: 10.1371/journal.pone.0201296. eCollection 2018.

2.

Erratum to "Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2" [Toxicol. in Vitro 46 (2018) 323-334].

Denel-Bobrowska M, Łukawska M, Bukowska B, Gajek A, Oszczapowicz I, Marczak A.

Toxicol In Vitro. 2018 Apr;48:350-352. doi: 10.1016/j.tiv.2018.01.003. Epub 2018 Feb 9. No abstract available.

PMID:
29433847
3.

Genetic predictors associated with diabetic retinopathy in patients with diabetic foot.

Mrozikiewicz-Rakowska B, Łukawska M, Nehring P, Szymański K, Sobczyk-Kopcioł A, Krzyżewska M, Maroszek P, Płoski R, Czupryniak L.

Pol Arch Intern Med. 2018 Jan 31;128(1):35-42. doi: 10.20452/pamw.4144. Epub 2017 Nov 7.

4.

Molecular mechanism of action of oxazolinoanthracyclines in cells derived from human solid tumors. Part 2.

Denel-Bobrowska M, Łukawska M, Bukowska B, Gajek A, Oszczapowicz I, Marczak A.

Toxicol In Vitro. 2018 Feb;46:323-334. doi: 10.1016/j.tiv.2017.10.021. Epub 2017 Oct 21. Erratum in: Toxicol In Vitro. 2018 Feb 9;:.

PMID:
29066354
5.

In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs.

Mazur L, Opydo-Chanek M, Śladowska K, Janota B, Kłaput U, Łukawska M, Oszczapowicz I.

Anticancer Res. 2017 Nov;37(11):6363-6372.

PMID:
29061821
6.

Effects of structural modification of the daunosamine moiety of anthracycline antibiotics on pKa values determined by capillary zone electrophoresis.

Matyjaszczyk K, Kolonko M, Gonciarz-Dytman A, Oszczapowicz I, Łukawska M, Jawień W, Chlopicki S, Walczak M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Aug 15;1060:44-52. doi: 10.1016/j.jchromb.2017.04.038. Epub 2017 Apr 24.

PMID:
28599260
7.
8.

Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors.

Denel-Bobrowska M, Łukawska M, Rogalska A, Forma E, Bryś M, Oszczapowicz I, Marczak A.

Toxicol Appl Pharmacol. 2016 Dec 15;313:159-169. doi: 10.1016/j.taap.2016.10.018. Epub 2016 Oct 22.

PMID:
27780733
9.

Dopa-responsive dystonia or early-onset Parkinson disease - Genotype-phenotype correlation.

Potulska-Chromik A, Hoffman-Zacharska D, Łukawska M, Kostera-Pruszczyk A.

Neurol Neurochir Pol. 2017 Jan - Feb;51(1):1-6. doi: 10.1016/j.pjnns.2016.07.013. Epub 2016 Sep 12.

PMID:
27667361
10.

Spectroscopic studies of anthracyclines: Structural characterization and in vitro tracking.

Szafraniec E, Majzner K, Farhane Z, Byrne HJ, Lukawska M, Oszczapowicz I, Chlopicki S, Baranska M.

Spectrochim Acta A Mol Biomol Spectrosc. 2016 Dec 5;169:152-60. doi: 10.1016/j.saa.2016.06.035. Epub 2016 Jun 24.

PMID:
27372511
11.

Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study.

Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba AM, Lukawska M, Chojnowska N, Kozka M, Bujalska-Zadrozny M, Ploski R, Krzymien J, Czupryniak L.

J Physiol Pharmacol. 2015 Oct;66(5):751-61.

12.

Subcellular localization of anthracyclines in cultured rat cardiomyoblasts as possible predictors of cardiotoxicity.

Studzian K, Kik K, Lukawska M, Oszczapowicz I, Strek M, Szmigiero L.

Invest New Drugs. 2015 Oct;33(5):1032-9. doi: 10.1007/s10637-015-0276-9. Epub 2015 Aug 14.

13.

Formamidinodoxorubicins are more potent than doxorubicin as apoptosis inducers in human breast cancer cells.

Marczak A, Denel-Bobrowska M, Łukawska M, Oszczapowicz I.

Anticancer Res. 2015 Apr;35(4):1935-40.

PMID:
25862845
14.

Nuclear accumulation of anthracyclines in the endothelium studied by bimodal imaging: fluorescence and Raman microscopy.

Majzner K, Wojcik T, Szafraniec E, Lukawska M, Oszczapowicz I, Chlopicki S, Baranska M.

Analyst. 2015 Apr 7;140(7):2302-10. doi: 10.1039/c4an01882f.

PMID:
25599102
15.

Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells.

Marczak A, Denel-Bobrowska M, Rogalska A, Łukawska M, Oszczapowicz I.

Environ Toxicol Pharmacol. 2015 Jan;39(1):369-83. doi: 10.1016/j.etap.2014.11.023. Epub 2014 Dec 18.

PMID:
25561091
16.

Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin.

Stojak M, Lukawska M, Oszczapowicz I, Opydo-Chanek M, Mazur L.

Anticancer Res. 2014 Dec;34(12):7151-8.

PMID:
25503143
17.

In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.

Stojak M, Mazur L, Opydo-Chanek M, Lukawska M, Oszczapowicz I.

Anticancer Res. 2013 Oct;33(10):4439-43.

PMID:
24123013
18.

Effects of structural modifications of daunorubicin on in vitro antileukemic activity.

Stojak M, Mazur L, Opydo-Chanek M, Lukawska M, Oszczapowicz I.

Anticancer Res. 2012 Dec;32(12):5271-7.

PMID:
23225426
19.

Oxazolinodoxorubicin - a promising new anthracycline.

Lukawska M, Klopotowska D, Milczarek M, Wietrzyk J, Studzian K, Szmigiero L, Porebska A, Oszczapowicz I.

Anticancer Res. 2012 Jul;32(7):2959-65.

PMID:
22753760
20.

Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moiety.

Lukawska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I.

Invest New Drugs. 2010 Oct;28(5):600-8. doi: 10.1007/s10637-009-9299-4. Epub 2009 Aug 28.

PMID:
19711013
21.
22.

[Analysis of deaths in cases of endocarditis in the I Klinika chorob wewnetrzynch A.M. in Warsaw during 1945-1958].

CZARNIECKI W, LUKAWSKA M.

Pol Arch Med Wewn. 1960;30:345-9. Polish. No abstract available.

PMID:
13813488
23.

[3 Cases of mandibular fracture in boxers].

LUKAWSKA M.

Pol Tyg Lek (Wars). 1959 Mar 30;14(13):580-4. Polish. No abstract available.

PMID:
13667631
24.

[Splenectomy in hematological diseases observed at the First Internal Clinic of the Academy of Medicine in Warsaw].

MIGDALSKA Z, LUKAWSKA M.

Pol Arch Med Wewn. 1959;29(3):349-50. Polish. No abstract available.

PMID:
13667690
25.

[Degenerative lesions of bones in athletes].

LUKAWSKA M.

Pol Arch Med Wewn. 1958;28(3):401-14. Polish. No abstract available.

PMID:
13553981

Supplemental Content

Loading ...
Support Center